Cumulative glycemia and microangiopathy in subjects with impaired glucose regulation in the Inter99 study

Diabetes Research and Clinical Practice

Volumn 91, Issue 2, 2011, Pages 226-232

  Munch, Inger Christine ^a,b   Larsen, Michael ^a,b   Kessel, Line ^a   Borch Johnsen, Knut ^c,d   Lund Andersen, Henrik ^a,b,c   Glümer, Charlotte ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STENO DIABETES CENTER   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Impaired glucose regulation; Lens fluorescence; Microalbuminuria; Retinopathy

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FLUORESCENCE ANALYSIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POPULATION RESEARCH; PREVALENCE; RETINOPATHY; RISK FACTOR;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED;

EID: 79952042630     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.10.017     Document Type: Article

References (35)

1. Narayan K.M., Boyle J.P., Thompson T.J., Sorensen S.W., Williamson D.F. Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884-1890.
2. Johnson S.L., Tabaei B.P., Herman W.H., The Efficacy Cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. Diabet Care 2005, 28:307-311.
3. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003, 361:2005-2016. Heart Protection Study Collaborative Group.
4. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. New Engl J Med 2008, 358:580-591.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
6. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352:854-865. UK Prospective Diabetes Study (UKPDS) Group.
7. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998, 317:703-713. UK Prospective Diabetes Study (UKPDS) Group.
8. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 2001, 344:1343-1350.
9. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world-a growing challenge. New Engl J Med 2007, 356:213-215.
10. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002, 346:393-403. Diabetes Prevention Program Research Group.
11. Nathan D.M., Davidson M.B., DeFronzo R.A., Heine R.J., Henry R.R., Pratley R., et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabet Care 2007, 30:753-759.
12. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 2005, 67:3-21.
13. Monnier V.M., Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981, 211:491-493.
14. Bleeker J.C., Van Best J.A., Vrij L., van der Velde E.A., Oosterhuis J.A. Autofluorescence of the lens in diabetic and healthy subjects by fluorophotometry. Invest Ophthalmol Vis Sci 1986, 27:791-794.
15. Lynnerup N., Kjeldsen H., Heegaard S., Jacobsen C., Heinemeier J. Radiocarbon dating of the human eye lens crystallines reveal proteins without carbon turnover throughout life. PLoS ONE 2008, 3:e1529.
16. Larsen M., Kjer B., Bendtson I., Dalgaard P., Lund-Andersen H. Lens fluorescence in relation to metabolic control of insulin-dependent diabetes mellitus. Arch Ophthalmol 1989, 107:59-62.
17. Jorgensen T., Borch-Johnsen K., Thomsen T.F., Ibsen H., Glumer C., Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur J Cardiovasc Prev Rehabil 2003, 10:377-386.
18. Glumer C., Jorgensen T., Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a danish population: the Inter99 study. Diabet Care 2003, 26:2335-2340.
19. Kessel L., Hougaard J.L., Mortensen C., Jorgensen T., Lund-Andersen H., Larsen M. Visual acuity and refractive errors in a suburban Danish population: Inter99 Eye Study. Acta Ophthalmol Scand 2004, 82:19-24.
20. Cantrill H.L. The diabetic retinopathy study and the early treatment diabetic retinopathy study. Int Ophthalmol Clin 1984, 24:13-29.
21. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and classification of diabetes mellitus, 1999.
22. Eknoyan G., Hostetter T., Bakris G.L., Hebert L., Levey A.S., Parving H.H., et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney 2003, 42:617-622.
23. Kessel L., Sander B., Dalgaard P., Larsen M. Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study. Br J Ophthalmol 2004, 88:1169-1172.
24. Sparrow J.M., Bron A.J., Brown N.A., Neil H.A. Autofluorescence of the crystalline lens in early and late onset diabetes. Br J Ophthalmol 1992, 76:25-31.
25. Kessel L., Hougaard J.L., Sander B., Kyvik K.O., Sorensen T.I., Larsen M. Lens ageing as an indicator of tissue damage associated with smoking and non-enzymatic glycation-a twin study. Diabetologia 2002, 45:1457-1462.
26. Kessel L., Jorgensen T., Glumer C., Larsen M. Early lens aging is accelerated in subjects with a high risk of ischemic heart disease: an epidemiologic study. BMC Ophthalmol 2006, 6:16.
27. Cowie C.C., Rust K.F., Ford E.S., Eberhardt M.S., Byrd-Holt D.D., Li C., et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabet Care 2009, 32:287-294.
28. Rhee M.K., Herrick K., Ziemer D.C., Vaccarino V., Weintraub W.S., Narayan K.M., et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabet Care 2010, 33:49-54.
29. Christensen D.L., Witte D.R., Kaduka L., Jorgensen M.E., Borch-Johnsen K., Mohan V., et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabet Care 2010, 33:580-582.
30. Lambers Heerspink H.J., Brantsma A.H., de Zeeuw D., Bakker S.J.L., de Jong P.E., Gansevoort R.T., et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 2008, 168:897-905.
31. Bryson C.L., Ross H.J., Boyko E.J., Young B.A. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006, 48:720-726.
32. Yu T., Mitchell P., Berry G., Li W., Wang J.J. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998, 116:83-89.
33. Mitchell P., Smith W., Wang J.J., Attebo K. Prevalence of diabetic retinopathy in an older community: the blue mountains eye study. Ophthalmology 1998, 105:406-411.
34. van Leiden H.A., Dekker J.M., Moll A.C., Nijpels G., Heine R.J., Bouter L.M., et al. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabet Care 2002, 25:1320-1325.
35. McCance D.R., Hanson R.L., Charles M.A., Jacobsson L.T., Pettitt D.J., Bennett P.H., et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994, 308:1323-1328.